Skip to main content
Watch Insiders
AMLXHealthcare

Amylyx Pharmaceuticals Inc (AMLX) Insider Trading

In the last 90 days, 6 Amylyx Pharmaceuticals Inc (AMLX) insiders reported no open-market purchases and 6 sales totaling $3,775,868. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 5, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 5, 2026George M Milne JrDirectorSale30,000$27.70$830,904
Sep 10, 2026Camille L BedrosianChief Medical OfficerSale10,028$32.40$324,868
Sep 10, 2026James M FratesChief Financial OfficerSale10,810$32.36$349,820
Sep 10, 2026Gina MazzarielloChief Legal OfficerSale9,536$32.46$309,506
Sep 10, 2026Joshua B CohenCo-Chief Executive OfficerSale30,464$32.19$980,505
Sep 10, 2026Justin B. KleeCo-Chief Executive OfficerSale30,464$32.18$980,264
Jul 10, 2026Gina MazzarielloChief Legal OfficerSale30,000$17.96$538,869
May 21, 2026Karen FirestoneDirectorOpen Market Purchase3,800$13.51$51,338

Common questions

AMLX insider trading FAQ

Are AMLX insiders buying or selling?
Over the last 90 days, AMLX insiders were net sellers, reporting $0.00 of open-market purchases and $3,775,868 of sales.
When was the last AMLX insider purchase?
No open-market insider purchase of Amylyx Pharmaceuticals Inc stock was reported in the last 90 days.
Where does AMLX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Amylyx Pharmaceuticals Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.